0001079973-24-000085.txt : 20240119
0001079973-24-000085.hdr.sgml : 20240119
20240119110121
ACCESSION NUMBER: 0001079973-24-000085
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240117
FILED AS OF DATE: 20240119
DATE AS OF CHANGE: 20240119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schornstein Alexander
CENTRAL INDEX KEY: 0001999256
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35005
FILM NUMBER: 24544268
MAIL ADDRESS:
STREET 1: KAISER-FRIEDRICH-ALLEE 2
CITY: AACHEN
STATE: 2M
ZIP: 52074
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001426800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO TOWER PLACE
STREET 2: 7TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (833) 409-4583
MAIL ADDRESS:
STREET 1: TWO TOWER PLACE
STREET 2: 7TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC
DATE OF NAME CHANGE: 20080211
4
1
ownership.xml
X0508
4
2024-01-17
0
0001426800
ASSEMBLY BIOSCIENCES, INC.
ASMB
0001999256
Schornstein Alexander
KAISER-FRIEDRICH-ALLEE 2
AACHEN
2M
52074
GERMANY
0
0
1
0
0
Common Stock
2024-01-17
4
P
0
299994
0.784
A
7864286
D
Common Stock
2024-01-18
4
P
0
345086
0.80
A
8209372
D
The sales reported on this Form 4 represent shares purchased by the reporting person from January 17, 2024, to January 18, 2024, from the open market using his personal funds.
The price reported is the midpoint of the price range at which the shares were purchased. 299,994 shares were purchased on January 17, 2024, in multiple transactions at prices ranging from $0.768 to $0.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
345,086 shares were purchased on January 18, 2024, in multiple transactions at $0.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
/s/ Alexander Schornstein
2024-01-19